Form 4: Aspen Aerogels Director Kool Kathleen Reports Acquisition of Stock Options and Restricted Stock Units

Director Kathleen Kool reports the acquisition of stock options and restricted stock units (RSUs) in Aspen Aerogels, Inc. as part of her annual equity grant for service as a non-employee director.

Summary

• Kathleen Kool, a director at Aspen Aerogels, Inc., filed a Form 4 detailing changes in her beneficial ownership of the company's securities.
• On April 30, 2025, Kool was granted 10,370 Restricted Stock Units (RSUs) and 9,105 stock options as part of her annual equity grant for service as a non-employee director.
• The RSUs represent the right to receive one share of Common Stock upon vesting, and the options represent the right to buy common stock at an exercise price of $5.40.
• Both the RSUs and options will vest on the earlier of April 30, 2026, or the day prior to the Issuer's annual meeting of stockholders to be held in 2026.
• Following the reported transaction, Kool beneficially owns 23,953 shares of Common Stock (including 13,583 shares of Common Stock and 10,370 RSUs) and 9,105 stock options.

Sentiment

Score: 7

Explanation: The document is a standard regulatory filing detailing equity compensation for a director. It's neutral in tone and reflects standard corporate governance practices. The sentiment is slightly positive as it indicates alignment of interests between the director and shareholders.

Positives

• The grant of RSUs and stock options to a director aligns her interests with those of the shareholders.
• The vesting schedule encourages continued service on the board.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's future performance, but the equity grants suggest an expectation of continued service and contribution from the director.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Equity grants are a common way to compensate and incentivize directors.

Comparison to Industry Standards

• Equity compensation for non-employee directors varies widely across industries and company sizes.
• Comparing the size and structure of these grants to those of directors at similar companies (e.g., other materials science or technology firms) would provide a more complete picture of their relative value.
• Companies like Cabot Corporation or Rogers Corporation could be considered peers for comparison purposes.

Stakeholder Impact

• The equity grants align the director's interests with those of the shareholders, potentially encouraging decisions that increase shareholder value.

Key Dates

Keywords

Form 4, Aspen Aerogels, Director, Kathleen Kool, RSUs, Stock Options, Beneficial Ownership, Equity Grant